3 years ago

Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis

Exploiting macrophage autophagy-lysosomal biogenesis as a therapy for atherosclerosis
Daping Fan, Carl J. Stokes, Paul S. Micevych, Babak Razani, Joel D. Schilling, Ali Javaheri, Karyn B. Holloway, Trent D. Evans, Slava Epelman, Somashubhra Bhattacharya, Xiangyu Zhang, Mohamed A. Zayed, Babak Dehestani, Ismail Sergin, Conrad C. Weihl, Eric Song, Jan R. Crowley, Abhinav Diwan, Andrea Ballabio, Sahl Ali
Macrophages specialize in removing lipids and debris present in the atherosclerotic plaque. However, plaque progression renders macrophages unable to degrade exogenous atherogenic material and endogenous cargo including dysfunctional proteins and organelles. Here we show that a decline in the autophagy–lysosome system contributes to this as evidenced by a derangement in key autophagy markers in both mouse and human atherosclerotic plaques. By augmenting macrophage TFEB, the master transcriptional regulator of autophagy–lysosomal biogenesis, we can reverse the autophagy dysfunction of plaques, enhance aggrephagy of p62-enriched protein aggregates and blunt macrophage apoptosis and pro-inflammatory IL-1β levels, leading to reduced atherosclerosis. In order to harness this degradative response therapeutically, we also describe a natural sugar called trehalose as an inducer of macrophage autophagy–lysosomal biogenesis and show trehalose’s ability to recapitulate the atheroprotective properties of macrophage TFEB overexpression. Our data support this practical method of enhancing the degradative capacity of macrophages as a therapy for atherosclerotic vascular disease.

Publisher URL: http://www.nature.com/articles/ncomms15750

DOI: 10.1038/ncomms15750

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.